5-Aminolevulinate synthase catalyzes the pyridoxal 5-phosphate-dependent condensation of glycine and succinyl-CoA to produce carbon dioxide, CoA, and 5-aminolevulinate, in a reaction cycle involving the mechanistically unusual successive cleavage of two amino acid substrate ␣-carbon bonds. Single and multiple turnover rapid scanning stopped-flow experiments have been conducted from pH 6.8 -9.2 and 5-35°C, and the results, interpreted within the framework of the recently solved crystal structures, allow refined characterization of the central kinetic and chemical steps of the reaction cycle. Quinonoid intermediate formation occurs with an apparent pK a of 7.7 ؎ 0.1, which is assigned to His-207 acid-catalyzed decarboxylation of the ␣-amino--ketoadipate intermediate to form an enol that is in rapid equilibrium with the 5-aminolevulinatebound quinonoid species. Quinonoid intermediate decay occurs in two kinetic steps, the first of which is acid-catalyzed with a pK a of 8.1 ؎ 0.1, and is assigned to protonation of the enol by Lys-313 to generate the product-bound external aldimine. The second step of quinonoid decay defines k cat and is relatively pHindependent and is assigned to opening of the active site loop to allow ALA dissociation. The data support important refinements to both the chemical and kinetic mechanisms and indicate that 5-aminolevulinate synthase operates under the stereoelectronic control predicted by Dunathan's hypothesis.
5-Aminolevulinate synthase (ALAS)3 is a homodimeric pyridoxal 5Ј-phosphate (PLP)-dependent enzyme that is evolutionarily related to transaminases and catalyzes the first committed step of tetrapyrrole synthesis in non-plant eukaryotes, as well as the ␣-subclass of purple bacteria (1-3). Many organisms, including animals and some bacteria, are known to encode two genetically distinct ALAS genes. In animals one of these genes is expressed exclusively in developing erythrocytes, and mutations in the human erythroid-specific ALAS are correlated with hereditary X-linked sideroblastic anemia, a blood disorder characterized by iron-overloaded, heme-deficient red cells (4).PLP-dependent enzymes catalyze a wide variety of reactions, including transaminations, decarboxylations, racemizations, and retro-aldol cleavages (5, 6). In the vast majority of cases the biochemical versatility of PLP can be rationalized in terms of a single property of the cofactor, the potential to act as an electron sink, and stabilize negative charge at the ␣-carbon of the substrate amino acid. Electrons from cleaved bonds of the covalently bound substrate can delocalize into the conjugated pyridine ring system to form quinonoid intermediates, which are often sufficiently stable to be spectroscopically observable and are characterized by strong absorption maxima of ϳ500 nm. These and other changes in the spectroscopic properties of the PLP cofactor during partial or complete reaction cycles can provide important insights into the chemical and kinetic properties of these enzymes.The generally accepted chemical me...